Showing results (1151-1160 of 1,559) with videos related to

Sort By:
Pageof 156
Cancer Research|August 27, 2009
RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancerCory Iverson, Gary Larson, Chon Lai, et al.
Neurourology and Urodynamics|February 19, 2021
Comparison of deep phenotyping features of UCPPS with and without Hunner lesion: A MAPP-II Research Network StudyH Henry Lai, Craig Newcomb, Steve Harte, et al.
International Journal of Cancer|December 6, 2011
Vitamins, minerals, essential fatty acids and colorectal cancer risk in the United Kingdom Dietary Cohort ConsortiumTimothy J Key, Paul N Appleby, Gabriel Masset, et al.
Psychological Medicine|March 24, 2025
Minimal clinically important differences for treatment of hallucinations in Parkinson's disease and dementia with Lewy bodiesSuzanne Reeves, Josef Mahdi, Matthew Appleby, et al.
Environmental and Molecular Mutagenesis|April 22, 2024
AOP report: Development of an adverse outcome pathway for deposition of energy leading to cataractsEmma Carrothers, Meghan Appleby, Vita Lai, et al.
IEEE Nuclear Science Symposium Conference Record. Nuclear Science Symposium|November 17, 2015
Tomographic Small-Animal Imaging Using a High-Resolution Semiconductor CameraG A Kastis, M C Wu, S J Balzer, et al.
Thrombosis and Haemostasis|October 1, 1995
Inhibition of thrombin by peptides containing Lysyl-alpha-keto carbonyl derivativesS D Lewis, A S Ng, E A Lyle, et al.
Annals of the American Thoracic Society|January 19, 2024
Electrocardiographic Abnormalities and Their Association with Outcomes in Randomized Clinical Trials of Pulmonary Arterial HypertensionJasleen Minhas, Jude Moutchia, Nadine Al-Naamani, et al.
Neuroimage. Clinical|September 8, 2019
Acquisition of sensorimotor fMRI under general anaesthesia: Assessment of feasibility, the BOLD response and clinical utilityAdam Kenji Yamamoto, Joerg Magerkurth, Laura Mancini, et al.
Organic Letters|May 7, 2005
Efficient synthesis of an imidazole-substituted delta-amino acid by the integration of chiral technologiesIan Appleby, Lee T Boulton, Christopher J Cobley, et al.
Pageof 156